Marimed (MRMD) Long-Term Investments (2015 - 2024)

Marimed (MRMD) has reported Long-Term Investments for 10 consecutive years, with $274000.0 the latest figure, recorded in Q1 2024.

• On a quarterly basis, Long-Term Investments changed N/A year-over-year to $274000.0 in Q1 2024; TTM through Mar 2024 was $274000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $221000.0, changed N/A from the prior year.
• Long-Term Investments was $274000.0 for Q1 2024 at Marimed, up from $221000.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $2.5 million in Q4 2020 and troughed at $89000.0 in Q2 2023.
• A 5-year average of $1.2 million and a median of $1.4 million in 2022 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments slumped 94.9% in 2020 and gained 18.74% in 2021, its largest moves.
• Over 5 years, Long-Term Investments stood at $2.5 million in 2020, then slumped by 90.05% to $251000.0 in 2021, then jumped by 439.04% to $1.4 million in 2022, then tumbled by 83.67% to $221000.0 in 2023, then grew by 23.98% to $274000.0 in 2024.
• The last three Long-Term Investments figures came in at $274000.0 (Q1 2024), $221000.0 (Q4 2023), and $164000.0 (Q3 2023), per Business Quant data.